Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Intravenous Immunglobulin (IVIG) in Patients With Heart Failure After Myocardial Infarction

NCT00430885 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT00430885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Intravenous Immunglobulin (IVIG) in Patients With Heart Failure After Myocardial Infarction
Lead sponsor
Oslo University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2010
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction